Hearing patients’ plight, desi firm starts making drug for rare disease

Share This Post

Mumbai: Almost 18 months after patients of a rare genetic condition called Wilson’s Disease suffered due to an acute shortage of a life-saving drug called D-Pencillamine across the country, there is finally a reason to cheer. An Indian company has begun manufacturing a drug called Trientine, which is considered superior to D-Pencillamine due to fewer side-effects at a fraction of its international price.

Read more at:
http://timesofindia.indiatimes.com/articleshow/68446117.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

About Dr. Aabha Nagral

Dr. Aabha Nagral is one of India’s leading Hepatologists (Liver specialist) based in Mumbai. Having an experience of around 30 years, she has been successfully treating patients of all liver diseases from India and abroad. She is skilled and known for solving complex problems in her field of specialization which includes Liver diseases and Liver Transplantation in adults & children.

She has been instrumental in setting up the first liver transplant programs at Jaslok Hospital and subsequently at Apollo Hospital, Mumbai. She was involved in the first successful pediatric liver transplant in Western India.

Dr. Aabha Nagral has been a founding trustee of the NGO – Children’s Liver Foundation which was set up to create awareness about liver diseases in children.

About Dr. Aabha Nagral

More To Explore

Connect with Dr. Aabha Nagral

Dr. Aabha Nagral is one of India’s leading hepatologists (liver specialist) based in Mumbai. Having an experience of over 30 years, she has been successfully treating patients of all liver diseases from India and aboard.